Risankizumab

Definition: Risankizumab, sold under the brand name Skyrizi ( sky-RIZZ-ee), is a humanized monoclonal antibody used for the treatment of plaque psoriasis, psoriatic arthritis, Crohn's disease, and ulcerative colitis. It is designed to target interleukin 23A (IL-23A). source: Wikipedia

ID

787732000

ID date

8 Sep 2021

Previous ID

37021911000001100

Name

Risankizumab